María Dolores Caballero Barrigón-rekin lankidetzan egindako argitalpenak (54)

2013

  1. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients

    British Journal of Haematology, Vol. 162, Núm. 4, pp. 474-482

2012

  1. Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

    Transfusion, Vol. 52, Núm. 5, pp. 1086-1091

2011

  1. Effect of vitamin D treatment in chronic GVHD

    Bone Marrow Transplantation

2010

  1. Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

    American Journal of Hematology, Vol. 85, Núm. 4, pp. 290-293

2009

  1. Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 15, Núm. 10, pp. 1331-1336

2008

  1. Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy

    Biology of Blood and Marrow Transplantation, Vol. 14, Núm. 10, pp. 1163-1171

  2. Reduced-Intensity Conditioning Allogeneic Transplantation from Unrelated Donors: Evaluation of Mycophenolate Mofetil Plus Cyclosporin A as Graft-versus-Host Disease Prophylaxis

    Biology of Blood and Marrow Transplantation, Vol. 14, Núm. 6, pp. 664-671

2006

  1. Chronic graft-versus-host disease: Pathogenesis and clinical management

    Drugs, Vol. 66, Núm. 8, pp. 1041-1057

  2. Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)

    Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941

  3. Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients [14]

    Leukemia

  4. Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy [5]

    Bone Marrow Transplantation

2005

  1. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)

    Clinical Cancer Research, Vol. 11, Núm. 21, pp. 7757-7763

  2. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma

    Haematologica, Vol. 90, Núm. 1, pp. 78-85

  3. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena

    American Journal of Hematology, Vol. 78, Núm. 4, pp. 302-305

  4. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 6, pp. 437-447

  5. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.

    Haematologica, Vol. 90, Núm. 12 Suppl

2004

  1. Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation

    Bone Marrow Transplantation, Vol. 33, Núm. 2, pp. 183-187

  2. Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantation

    Leukemia and Lymphoma, Vol. 45, Núm. 9, pp. 1725-1729

  3. Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: A single-centre sequential-cohort study

    Bone Marrow Transplantation, Vol. 34, Núm. 8, pp. 675-682

2003

  1. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: A feasibility study

    Haematologica, Vol. 88, Núm. 5, pp. 555-560